-
As to hospitalized patients, the presence of hyponatremia is associated with a worse prognosis, but there aren’t many data on the association between hyponatremia and prognosis in the general population. Some researchers in Denmark have evaluated plasmatic levels of sodium in 671 subjects averagely 65, not affected by heart diseases, stroke, cancer or other important diseases.
MedNews (Nefrologia) - Lun, 1 Marzo 2010
http://mn.medsurfnews.com/
-
From previous trials, we know that the decreased function is associated with an increased cardiovascular risk and with a greater probability of death for any cause. But these trials are performed on high-cardiovascular-risk subjects, on subjects with present CV diseases and on subjects with impaired renal function. In order to evaluate nephrological importance in people with no such risks 28,000 women have been analyzed, enrolled in the Women’s Health Study, with no cardiovascular diseases and being at least 45.
MedNews (Nefrologia) - Ven, 5 Febbraio 2010
http://mn.medsurfnews.com/
-
This multicenter, randomized trial compared the effect of continuous renal-replacement therapy at two different levels of intensity on 90-day mortality among critically ill adults with acute kidney injury. The higher-intensity therapy did not reduce mortality at 90 days.
New England Journal of Medicine (Nefrologia) - Lun, 26 Ottobre 2009
http://www.nejm.org
-
Every year more than 1 million hospitalizations in the United States are complicated by acute kidney injury, accounting for an estimated $10 billion in excess costs to the health care system. Acute kidney injury has been shown to be a potent predictor of excess length of stay, morbidity, and mortality in a number of clinical settings.
Journal of the American Medical Association (Nefrologia) - Ven, 18 Settembre 2009
http://jama.ama-assn.org/
-
Ferumoxytol injection may be more effective than oral iron for anemic patients in all stages of chronic kidney disease.
Medscape (Nefrologia) - Ven, 3 Luglio 2009
http://www.medscape.com
-
Just over 50 years ago, the late David Jones1 identified (using the periodic acid-Schiff and methenamine silver stains) the unique glomerular pathologic features of membranous nephropathy, thus distinguishing it from other causes of "nephrotic glomerulonephritis.
New England Journal of Medicine (Nefrologia) - Ven, 3 Luglio 2009
http://www.nejm.org
-
Polycystic kidney disease — Comprehensive overview covers symptoms, treatment, prevention of this kidney condition.
MayoClinic.com (Nefrologia) - Ven, 3 Luglio 2009
http://www.mayoclinic.com
-
Current predictions estimate that by the year 2020, more than 750,000 people in the United States alone will have end-stage renal disease and over 500,000 will require hemodialysis.
New England Journal of Medicine (Nefrologia) - Ven, 22 Maggio 2009
http://www.nejm.org
-
Application of a tissue-engineered vascular graft for small-diameter vascular reconstruction has been a long awaited and much anticipated advance for vascular surgery. We report results after a minimum of 6 months of follow-up for the first ten patients implanted with a completely biological and autologous tissue-engineered vascular graft.
The Lancet (Nefrologia) - Gio, 30 Aprile 2009
http://www.thelancet.com
-
In the first approach to acute hypercalcemia, many books of clinical medicine recommend the use of furosemide associated with saline infusions, so a research was performed in order to evaluate this practice with the use of bisphosphonates. 9 reports (the most recent one dating back to 1983) were identified, involving 37 patients treated with furosemide for acute hypercalcemia; the dose ranged from 240 to 2400 mg.
MedNews (Nefrologia) - Ven, 6 Febbraio 2009
http://mn.medsurfnews.com/